This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Expanding the potential patient population for pulsed field ablation, results from the SINGLE SHOT CHAMPION study suggest PFA might be just as good as cryoballoon ablation for patients with paroxysmal AFib. Atrial tachyarrhythmia recurred in 37.1% The post PFA or Cryoballoon for Paroxysmal AFib?
Drinking multiple cups of coffee a day may help prevent cognitive decline in people with atrialfibrillation (AFib or AF), according to new research published in the Journal of the American Heart Association.
A JACC study suggests that atrialfibrillation is far more prevalent than many previously thought, estimating that nearly one in 20 American adults have been diagnosed with the disease. UCSF researchers analyzed medical records from 29M adults who received hospital-based care in California from 2005 to 2019 (51yr avg.
16, 2025 Primary results from the DEFINE AFib clinical study show the Medtronic LINQ family of insertable cardiac monitors (ICM), paired with a novel algorithm, were able to detect atrialfibrillation episodes and properly risk stratify patients as high risk prior to an AF-related healthcare utilization 80% of the time.
(MedPage Today) -- CHICAGO -- Researchers failed to prevent cognitive impairment in people with existing atrialfibrillation (Afib) by going the route of anticoagulation to mitigate subclinical brain infarcts, according to the BRAIN-AF trial.
(MedPage Today) -- The efficacy of catheter ablation for heart failure (HF) patients with atrialfibrillation (Afib or AF) hinged on the phenotype of disease, researchers reported based on a meta-analysis. Compared with conventional rate or rhythm.
Research Highlights: Treating gum disease within three months after a heart procedure to correct an irregular heart rhythm, known as atrialfibrillation (AFib), may lower the chances of it reoccurring. Inflamed gums may predict AFib recurrence after.
A new artificial intelligence (AI) model designed by Scripps Research scientists could help clinicians better screen patients for atrialfibrillation (or AFib)—an irregular, fast heartbeat that is associated with stroke and heart failure.
Treating gum disease in the three months after a procedure to correct an irregular heartbeat known as atrialfibrillation (AFib) may lower oral inflammation and may reduce AFib recurrence, according to new research published today in the Journal of the American Heart Association.
Recent research has also found the incidence of atrialfibrillation (AFib), the most common type of irregular heart rhythm or arrhythmia, continues to rise, according to the study. Binge drinking (five drinks within two hours for men and four drinks within two hours for women) is common around the world.
September is National AtrialFibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Physicians have a crucial role in recognizing, diagnosing, and managing AFib to prevent its potentially life-threatening complications.
Research Highlights: A clinical trial with adults who have atrialfibrillation (AFib) and an implanted heart device found similar improvements to the amount of time they experienced arrhythmia regardless of whether they received standard care.
A BMJ study out of Denmark provided alarming new insights into atrialfibrillation’s impact on patients’ future cardiovascular health, while highlighting the need to improve post-AFib heart failure and stroke prevention. The researchers analyzed 2000-2022 data from 3.5M The researchers analyzed 2000-2022 data from 3.5M
A Cedars-Sinai-led team developed an echocardiography AI model that accurately detects patients with atrialfibrillation – including asymptomatic patients – potentially revealing a new “opportunistic screening” method to drive earlier AFib detection and treatment. AUC identifying patients with a history of AFib.
Atrialfibrillation (Afib), a common type of arrhythmia that is on the rise in people under the age of 65, is more dangerous in this increasingly younger population than previously thought, according to new research.
Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy AtrialFibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. 2,3 Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib.4 In: AF Symposium.; February 2-4; Boston.
Research Highlights: In the first large trial of its kind, the anti-clotting medication rivaroxaban did not lower the risk of cognitive decline, stroke or transient ischemic attack (TIA) in people younger than age 65 who had atrialfibrillation (AFib).
September is National AtrialFibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Physicians have a crucial role in recognizing, diagnosing, and managing AFib to prevent its potentially life-threatening complications.
Looking at specific substances in the blood of people with atrialfibrillation, a type of irregular heartbeat, could help identify who's at risk for a stroke despite taking blood-thinning medication to prevent one, new research suggests.
Bernard's Heart & Vascular Center , Jonesboro, Arkansas) mark a significant milestone in the pursuit of innovative solutions for non-valvular atrialfibrillation (NVAF) treatment. Patients with NVAF deemed appropriate for LAAX to reduce the risk of stroke and systemic embolism, will participate in this research effort.
Herein, we report results of a follow-up screening protocol for incident atrialfibrillation/flutter (AF) within a large observational digital health study. Research is needed to determine the implications of these alarms and appropriate follow-up.
Abstract Introduction Atrialfibrillation (Afib) is a prevalent chronic arrhythmia associated with severe complications, including stroke, heart failure, and increased mortality. Results/Observation Current Afib detection methods, such as electrocardiography, have limitations in sensitivity and specificity.
Compared with a sham procedure, pulmonary vein isolation resulted in a statistically significant and clinically important decrease in atrialfibrillation (AFib) burden at six months, according to results from the SHAM-PVI trial presented at ESC Congress 2024 in London and simultaneously published in JAMA.
Treatment with the Type 2 diabetes medication metformin, lifestyle changes, or a combination of both did not improve atrialfibrillation (AFib) burden or progression when compared with standard care, according to preliminary late-breaking science presented Nov. 18 at the American Heart Association's Scientific Sessions 2024.
Introduction:Anticoagulation (AC) is the mainstay of thromboprophylaxis for stroke prevention in atrialfibrillation (AF) and is recommended. We compared the risk of stroke, GIB, and mortality in 5 years.Results:A total of 19,427 patients with UGIB who have AFIB received oral apixaban were identified.
Prognostic impact of severe tricuspid regurgitation (TR) in patients with atrial functional mitral regurgitation (AFMR). Patients with severe TR were older, mostly with atrialfibrillation, and had more severe heart failure symptoms and more advanced left atrial and right heart remodelling than those with non-severe TR.
About a million possible cases of atrialfibrillation, a known risk for stroke, go undetected in Japan. The AI lineup currently covers both continuous ECG tracking and AFib detection. You are currently developing a new AI to detect AFib. This research was published prior to our product launch.
OSA is commonly seen in patients with arrhythmias like atrialfibrillation (AFib) and due to the variable unpredictable nature of sleep apnea symptoms, it is often untreated, leading to adverse outcomes. American Academy of Sleep Medicine – Association for Sleep Clinicians and Researchers. Kingshott, R. 2017, November 8).
11, 2025, at HonorHealth Research Institute, Rahul Doshi, M.D., Using the same catheter, he also was able to easily switch to radiofrequency ablation, which has traditionally been used to treat Afib by scarring the damaged part of the heart using heat. Learn more at HonorHealth.com/research. 12, 2025 On Feb. of the adult U.S.
19, 2024 Drinking multiple cups of coffee a day may help prevent cognitive decline in people withatrial fibrillation (AFib or AF), according to new research published in the Journal of the American Heart Association. tim.hodson Thu, 12/19/2024 - 14:35 Dec. Instead, say, Enjoy, it may even be good for you! said Jrg H.
"Based on the results from the admIRE clinical trial, we are confident that this innovation has the promise to deliver significant value and differentiated capabilities, and become an important tool for the treatment of AFib." 2,3 Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib. In the U.S.,
During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrialfibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.
milla1cf Wed, 12/13/2023 - 10:24 December 13, 2023 — A new artificial intelligence (AI) model designed by Scripps Research scientists could help clinicians better screen patients for atrialfibrillation (or AFib)—an irregular, fast heartbeat that is associated with stroke and heart failure.
Signify Research has just released a deep-dive qualitative analysis of developments around the use of AI to analyze and interpret electrocardiograms (ECGs), one of the world’s most ubiquitous diagnostic tests for cardiac disease. Fertile Partnerships Ongoing research partnerships have driven much of recent developments seen in the market.
Atrialfibrillation (AFib) cases have also surged, doubling from 28.3 Research points to low patient engagement as a predictive indicator of poor outcomes. Their adoption is crucial to counteracting the rising prevalence of strokes, AFib and other diseases that place immense pressure on already constrained providers.
The whole process can easily take 10-15 years and therefore patients may continue to be managed in sub-optimal manner for this duration of time even when there is available research to say that things could be done better. Today I wanted to talk about some troubling research in the field of AF. AF stands for atrialfibrillation.
Rate correction should not be used when RR interval has large variability, as in atrialfibrillation. AtrialFibrillation: These authors compared Bazett, Fridericia, and Framingham QT measurements on 54 patients with atrialfibrillation. Other Research: According to this study b y Batchvarov et al. ,
Boston Scientific made what could become a major addition to its electrophysiology portfolio, acquiring AFib mapping startup Cortex, Inc. Cortex gives Boston Scientific a new mapping technology that detects AFib signs and triggers outside of the pulmonary veins, and can help EP teams develop ablation strategies for more complex AFib cases.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content